← Open Payments lookup

MEGAN ERBES: Open Payments

NPI 1558933432 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,514 in 77 payments from 18 companies in 2025. Trend: 2023 $1,108 · 2024 $1,493 · 2025 $1,514

Food & beverage: $1,414Education: $100
CompanyPaymentsAmount
GlaxoSmithKline, LLC.14$241
AstraZeneca Pharmaceuticals LP4$215
Astellas Pharma US Inc4$194
Novo Nordisk Inc14$158
ABBVIE INC.9$135
Lilly USA, LLC9$120
Bayer Healthcare Pharmaceuticals Inc.5$90
Corcept Therapeutics3$71
Abbott Laboratories2$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$45

Products named: TRELEGY ELLIPTA, FARXIGA, UBRELVY, Veozah, Kerendia, Ozempic, MOUNJARO, Korlym.

Industry payments across AZ — which companies pay providers there.